Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Central Asia Tbk (BBCA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Bank Central Asia TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Central Asia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,225 (market cap 753.61T, 180.06M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 1289.1× UBC Medical Indonesia Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (180.06M versus 1.44M). Which is the better fit depends on your goals.

BBCALABS
Market Cap
753.61T584.6B
Volume
180.06M1.44M
Lot
1.8M14.4K
Turnover
1.11T209.72M
Average Price
6,176.89145.64
Value
1.11T209.72M
Indicative Equilibrium Price
6,225146
Indicative Equilibrium Volume
292.85K753

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BBCA
View details
LABS
View details

About Bank Central Asia Tbk

PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.

Read more on BBCA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS